Sense Biodetection rakes in $65m Series B

Sense Biodetection, a global molecular diagnostics firm, has raised $65 million in Series B funding.

Sense Biodetection, a global molecular diagnostics firm, has raised $65 million in Series B funding. Koch Disruptive Technologies, a subsidiary of Koch Industries Inc, led the round.

Source: Press Release